Fibrinogen / Prufibry / Fesilty (BT524)
Congenital fibrinogen deficiency
Key Facts
About Biotest Pharmaceuticals
Biotest Pharmaceuticals is a long-established, revenue-generating commercial biopharma company focused on plasma-derived biologics. It maintains a vertically integrated model, controlling plasma collection through its own network of centers. The company has a commercial portfolio for immunology, haematology, and intensive care, and is advancing a late-stage pipeline including next-generation immunoglobulins and novel therapies like Trimodulin for severe pneumonia.
View full company profileAbout Biotest Pharmaceuticals
Biotest Pharmaceuticals is a long-established, revenue-generating commercial biopharma company focused on plasma-derived biologics. It maintains a vertically integrated model, controlling plasma collection through its own network of centers. The company has a commercial portfolio for immunology, haematology, and intensive care, and is advancing a late-stage pipeline including next-generation immunoglobulins and novel therapies like Trimodulin for severe pneumonia.
View full company profile